ArticleJournal of medicinal chemistry2026

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

Francesco Fiorentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.